ISDA

Entry Detail

PDB ID:

5N5J

Keywords:

HYDROLASE

Title:

Human MMP12 in complex with 3-(5-(1,2-dithiolan-3-yl)pentanamido)propane-1-sulfonate

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2017-02-14

Release Date:

2017-11-01

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.80 Å

R-Value Free:

0.19

R-Value Work:

0.12

R-Value Observed:

0.12

Space Group:

C 1 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Macrophage metalloelastase
Mutations:F171D
Chain IDs:A
Chain Length:158
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P39900 Pfam ID:PF00413 EC:3.4.24.65

Ligand Molecules

8NT

HAE

Primary Citation

Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX).

Fragai, M, Comito, G, Di Cesare Mannelli, L, Gualdani, R, Calderone, V, Louka, A, Richichi, B, Francesconi, O, Angeli, A, Nocentini, A, Gratteri, P, Chiarugi, P, Ghelardini, C, Tadini-Buoninsegni, F, Supuran, C.T, Nativi, C.Show

J. Med. Chem. 60 9003 9011 (2017)

PMID: 29048889 DOI: 10.1021/acs.jmedchem.7b01237

Abstact

Oxaliplatin (OXA) is a valuable and largely used cancer drug which induces a serious and intractable neuropathy. The lipoyl-homotaurine derivative (ADM_12) reverts in vivo OXA-induced neuropathy, and it is an effective antagonist of the nociceptive sensor channel TRPA1. Unprecedentedly, this safe analgesic showed a synergy with OXA in vitro and proved to inhibit CA IX, a relevant therapeutic target, clearly interfering with pancreatic cancer cells' aggressiveness.

Legend

Protein

Chemical

Disease

Primary Citation of related structures